secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2026-06-08T21:00:43+00:00
Accession:  0001493152-26-027752
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Alan Weichselbaum departs; Andriy Mushak appointed fractional CFO at $6K/month
--------------------------------------------------------------------------------

- Alan Weichselbaum departs as CFO effective June 6, 2026; no disagreement cited.
- Andriy Mushak, CPA, appointed fractional CFO effective June 6, 2026; will serve as independent contractor.
- Mushak will receive $6,000 per month under a one-year consulting agreement with LMAM Consulting Group.
- Mushak has 20+ years accounting experience; previously at Baker Tilly US, LLP and co-founded LMAM in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315226027752/0001493152-26-027752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315226027752/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer